Fred Alger Management, LLC Coherus Bio Sciences, Inc. Transaction History

Fred Alger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $1.04 Million - $2.35 Million	-177,391 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $2.83 Million - $4.25 Million	-258,797 Reduced 59.33%	177,391 $2.29 Million
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $59,350 - $71,288	3,754 Added 0.87%	436,188 $6.96 Million
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $5.48 Million - $7.69 Million	432,434 New	432,434 $6.95 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $118M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.